Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor borneol esters reported by Schering AG

Dec. 11, 1996

Pharma Mar describes cytotoxic xenicane diterpenes

Dec. 11, 1996

Sugen reports antihyperproliferative agents

Dec. 10, 1996

British Biotech discontinues development of MMP inhibitor

Dec. 9, 1996

Access in-licenses polymer platinum compounds

Dec. 9, 1996

Bayer reveals sugar-modified cytostatic agents

Dec. 9, 1996

Varian, University of Arizona collaborate on methods of enhancing gene therapy efficacy

Dec. 6, 1996

Antitumor enhancers claimed by Taiho

Dec. 5, 1996

RPR continues research into taxanes

Dec. 5, 1996

Calydon's lead cancer therapeutic progresses toward clinical trials

Dec. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...